Hims & Hers Stock Crashes 15%: What You Need to Know

preview_player
Показать описание
Hims stock fell after the FDA said its GLP-1 product may no longer be in shortage and a competitor reported disappointing GLP-1 news. Is the stock's drop an overreaction?

For long-term investors, I think it is.
-----------------------------------------------------------------------------------------------------

Disclosure:

00:00 Market Reaction to HIMS and Hers Stock Drop
00:52 Understanding GLP-1 and Its Impact
02:03 Latest News and FDA Updates
03:19 Future Prospects for HIMS and Hers
05:16 Conclusion and Final Thoughts
Рекомендации по теме
Комментарии
Автор

I think the drop is due to poor Eli Lilly earnings

donmarvelous